We are thrilled to announce the new international partnership between Organex and Bioiberica S.A.U., a renowned and world-leading company in the biotechnology sector.
This contract, signed in July, highlights the implementation of our RAS (Regulatory Affairs Solution) system for managing product registrations at an international level. The Kickoff meeting was held at the beginning of this month and marks the official start of the project with the gathering of all involved teams. In this article, you will learn more about the advantages and details of this new partnership.
Project Details
The contract with Organex involves Bioiberica’s use of the RAS system to centralize and optimize the management of its internationally marketed product registrations.
Based in Barcelona, the Bioiberica team will use RAS to ensure regulatory compliance and efficiency in registration management, from production to commercialization in various countries.
Partnership Benefits
- Efficiency in Registration Management: The RAS system will allow Bioiberica to effectively centralize and manage all product registrations.
- Regulatory Compliance: With RAS, Bioiberica can easily track and meet the regulatory requirements of different markets, ensuring continuous compliance.
- Process Optimization: The implementation of RAS will contribute to the optimization of registration processes, providing greater agility and accuracy in Bioiberica’s operations.
We are excited about this collaboration and confident that the partnership with Bioiberica will further strengthen our international presence. This contract reflects Organex’s commitment to providing innovative and efficient solutions for the biotechnology industry, promoting excellence in quality and regulatory compliance.
About Bioiberica
Founded in 1975 and based in Barcelona, Bioiberica is a global powerhouse in the production of heparin, a crucial anticoagulant. Additionally, the company develops high-value biological and therapeutic molecules such as Chondroitin Sulfate, Glucosamine, and Hyaluronic Acid.
With over 100 products in its portfolio, Bioiberica is dedicated to improving human, animal, and plant health, operating in over 80 countries. Bioiberica is part of the SARIA Group, an organization renowned for producing renewable energy from animal by-products and organic waste.
To learn more about Bioiberica and its activities, visit https://www.bioiberica.com/en.
